32 Children ’s Medicines Recalled For Potential ‘ Microbial Contamination ’

(CBS Local) – King Bio is voluntarily recalling 32 children’s medicines because of potential “microbial contamination,” the company said in a statement on Wednesday. The medicines, which include those meant to relieve common illnesses including fever, cough, flu, tummy aches, nosebleeds, and earaches, were sold nationwide. According to the company, “the use of drugs products with microbial contamination could potentially result in increased infections that may require medical intervention, and could result in infections that could be life threatening to certain individuals.” No injuries or illnesses have been reported to date. The affected products were produced between August 2017 and April 2018. A small percentage of the items tested positive for microbial contamination, the company stated. King Bio says it is recalling the products “out of an abundance of caution.” A full list of the recalled medicines and lot numbers are available on the FDA’s website. The recall includes certain lots of 2-ounce bottles of the following products: DK Attention &Learning Enh. Chicken Pox Symptom Relief Children’s Appetite &Weight Children’s Appetite Enhance Children’s Cough Relief Children’s Fever Reliever Children’s Growth &Development DK Newborn Tonic DK Nosebleed Relief TonsilPlex Children’s Ear Relief Formula DK Teething DK Colic Relief Tummy Aches Kids Multi- Strain Flu...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News children's medication FDA Local TV Recall talkers Source Type: news

Related Links:

Conclusions Higher cardiovascular endurance may mitigate the relationship between poorer subjective sleep quality and lower EC thickness. Future longitudinal studies should examine the interactive effects of sleep and fitness on brain health among older and more vulnerable populations.
Source: Medicine and Science in Sports and Exercise - Category: Sports Medicine Tags: APPLIED SCIENCES Source Type: research
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced preliminary results from the Phase 1b CHRYSALIS-2 (NCT04077463) study evaluating RYBREVANT® (amivantamab-vmjw) in combination with lazertinib in the treatment of patients with non-small cell lung cancer (NSCLC) characterized by epidermal growth factor receptor (EGFR) exon 19 deletion or L858R mutations whose disease had progressed after treatment with osimertinib and platinum chemotherapy.[i] While previously reported results have demonstrated durable responses with RYBREVANT® in combination with ...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
September 19, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced a new analysis from the CHRYSALIS (NCT02609776) study evaluating RYBREVANT® (amivantamab-vmjw) monotherapy and a combination regimen with lazertinib in advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations who progressed after osimertinib.[1] The analysis showed higher activity and longer duration of response (DOR) in patients treated with the combination therapy, demonstrating the potential benefit of targeting the extracellular (outer) and cataly...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Although intellectual disability was included in the first description of Duchenne muscular dystrophy (DMD), the cognitive and neurodevelopmental (ND) components of DMD and Becker muscular dystrophy (BMD) remain overshadowed by their motor, cardiac, and pulmonary manifestations. To assess the ND comorbidity burden in dystrophinopathy patients at Le Bonheur Children's Hospital neuromuscular clinic, abstraction of the electronic medical record was performed for 46 patients. Diagnoses of ADHD, epilepsy, autism spectrum, obsessive compulsive, oppositional defiant, mood, anxiety, and sleep disorders, along with discussion of an...
Source: Neuromuscular Disorders - Category: Neurology Authors: Source Type: research
This study aims to investigate whether children with Duchenne muscular dystrophy (DMD) have sleep disorders in addition to evaluate the sleep quality and daytime sleepiness in mothers who are primary caregivers using questionnaires. Demographic and clinical data in addition to gross motor functional status of 24 patients with a DMD diagnosis were measured using gross motor function classification system (GMFCS). The patients were given the sleep disturbance scale for children (SDSC) in order to evaluate their sleep features.
Source: Neuromuscular Disorders - Category: Neurology Authors: Source Type: research
The decline of respiratory function in patients with Duchenne muscular dystrophy (DMD) leads to alteration of nocturnal gas exchange, with nocturnal hypoventilation (NH) representing the first manifestation. Current expert guidelines warrant the implementation of nocturnal non-invasive ventilation (NIV) when forced vital capacity (FVC)% falls below 50. However, there is limited evidence on the pulmonary function threshold correlating with the onset of NH. With this retrospective, longitudinal study on pediatric patients who underwent a sleep study (SS) at Great Ormond Street Hospital, London, between 2010-2020, we aim to i...
Source: Neuromuscular Disorders - Category: Neurology Authors: Source Type: research
The efficacy of avalglucosidase alfa compared to alglucosidase alfa as measured by the EuroQol 5-dimension 5-level (EQ-5D-5L) from the phase 3 COMET trial in late-onset Pompe disease (LOPD) is presented. EQ-5D-5L, a multi-attribute utility measure of health-related quality of life, was collected in treatment-na ïve LOPD patients. Change from baseline to week 49 in the five dimensions of EQ-5D-5L, including mobility, usual activities, self-care, pain/discomfort and anxiety/depression; the derived patient's health state/index (range: 0 to 1); and the visual analogue scale (VAS, self-rated health on a 0 [wor st health] t...
Source: Neuromuscular Disorders - Category: Neurology Authors: Source Type: research
This study aims to identify the predictors of dysphagia and aspiration in a cohort of people living with DM1 over a range of disease severity and stages.
Source: Neuromuscular Disorders - Category: Neurology Authors: Source Type: research
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social behaviors and communication. In rodents and humans, prenatal exposure to antiepileptic valproic acid is associated with an increased risk for autistic-like characteristics. One potential treatment is oxytocin, a prosocial neuropeptide that can be delivered intranasally. However, the sex-specific effects of valproic acid exposure and intranasal oxytocin treatment on behavior have not been fully explored. Pregnant Long Evans rats were administered valproic acid (500 mg/kg) or saline midday on gestational day 12, ...
Source: Behavioural Pharmacology - Category: Drugs & Pharmacology Tags: Research Reports Source Type: research
Depression and anxiety are common neuropsychiatric disorders that usually appear as comorbidities. The development of new drugs is crucial for safer and more effective clinical management of both disorders. Riparin A is a synthetic chemical analog of riparins that naturally occur in several medicinal plants. Marked pharmacological effects such as anxiolytic and antidepressant properties characterize this class of compounds. However, little is known about the potential anxiolytic and antidepressant effects of Riparin A. In this work, we showed that, unlike other riparins, Riparin A exerts only a very mild anxiolytic-like ef...
Source: Behavioural Pharmacology - Category: Drugs & Pharmacology Tags: Research Articles Source Type: research
More News: Anxiety | Bed Wetting | Candida | Child Development | Children | Cough | Enuresis | Epistaxis (Nosebleeds) | Health | Learning | Sleep Disorders | Sleep Medicine | Sports Medicine | Universities & Medical Training | Websites